MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
Student-led startup pursues award-winning treatment for patients with disruptions to their autonomic body processes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback